PA
AG

AeroSafe Global

Pioneering Cold Chain as a Service for reliable, sustainable biopharma delivery worldwide.

Visit Website

Known For

World’s largest full-cycle reusable parcel program with 98.7% recovery rate across 85 countries

Key Differentiators

  • World’s largest full-cycle reusable parcel program with 98.7% recovery rate across 85 countries
  • zero product excursions/loss
  • sustainability (65% CO2 reduction, 90% less landfill)
  • AI-driven predictive visibility via Delivery Intelligence Navigator

Overview

AeroSafe Global provides Cold Chain as a Service (CCaaS), delivering proprietary reusable thermal packaging, logistics management, temperature monitoring via control tower, and full-cycle reuse programs for temperature-sensitive biopharmaceutical shipments. They ensure safe last-mile delivery to patients and providers with extended temperature stability, real-time visibility, and high recovery rates. Their integrated solutions reduce product loss to zero, cut CO2 emissions by 65%, and minimize landfill waste by 90% compared to single-use options.AeroSafe Global website, LinkedIn

Services & Capabilities

  • Cold Chain as a Service (CCaaS)
  • reusable high-tech thermal packaging (extended duration >4 days)
  • control tower monitoring, measuring, modeling
  • temperature loggers
  • real-time visibility and predictive analytics
  • full-cycle return logistics and reuse program (98.7% recovery)
  • pay-per-use supply cha

Competitive Position

  • World’s largest full-cycle reusable parcel program with 98.7% recovery rate across 85 countries
  • zero product excursions/loss
  • sustainability (65% CO2 reduction, 90% less landfill)
  • AI-driven predictive visibility via Delivery Intelligence Navigator
  • extended duration packaging enables ground shipping.AeroSafe Global website, MassBio, PR Newswire

Recent Developments

2025: CEO Jay McHarg named Endeavor Outlier; partnership/masterclass with Novo Nordisk at LogiPharma EU on circular supply chain; Earth Day sustainability posts; joined MassBio (2026 spotlight); exhibiting at LogiPharma USA 2026. No major announcements in specified sources (FiercePharma etc.). Growth hiring posts.

Client & Partner Ecosystem

Majority of top 20 pharma companies; >50% US healthcare providers; partners/investors incl. Merck Global Health Innovation Fund, Peloton Equity, NewSpring, Wave Equity Partners; NASA (packaging tech); Novo Nordisk (partnership/case study)

Technology Platform

Delivery Intelligence Navigator™; Cold Chain Intel; Cold Chain Delivery Management platform; Digital Control Tower; Targeted Risk Improvement Program

Therapeutic Focus

broad/all

Target Customers

Biopharma companies, specialty pharmacies, healthcare providers, health systems, direct-to-patient programs

Sources